19 Jul 2013 12:18
RNS Number : 7377J
Advanced Oncotherapy PLC
19 July 2013
ADVANCED ONCOTHERAPY Plc
("Advanced Oncotherapy" or "the Company")
Advanced Oncotherapy was informed on 18 July 2013 that, as of 15 July 2013, Mr Michael Horgan was beneficially interested in a total of 36,666,667 ordinary shares in the Company which represents approximately 9.14% of the issued share capital of the Company.
For further information, please visit www.advancedoncotherapy.com or contact:
Michael Sinclair, Chief Executive | Sandy Jamieson | Jon Levinson/Lucy Williams | Simon Hudson |
Advanced Oncotherapy Plc | Libertas Capital Corporate Finance Ltd | Peterhouse Corporate Finance | Tavistock Communications |
(NOMAD & Joint Broker) | (Joint Broker) | (Financial PR & IR) | |
+44 20 3617 8739 | +44 20 3697 9495 | +44 20 7469 0930 | +44 20 7920 3150 |
This information is provided by RNS
The company news service from the London Stock Exchange
AVO.L (AVO)